Nuvamid is rated 3 out of 5 in the category biotechnology. Read and write reviews about Nuvamid. > Our Mission Nuvamid is a privately-owned pharmaceutical company committed to developing and manufacturing novel therapeutics to the treatment of diseases with high unmet medical need. > Our Research Nuvamid’s research is built upon the emerging scientific findings linking age-related disease pathologies with NAD metabolism. Nuvamid designed novel NAD metabolism modulators and gathered extensive preclinical data to develop a portfolio of drugs targeting immune disorders. > NAD Science Nicotinamide adenine dinucleotide (NAD) is essential to the function of all living cells. NAD versatile functions have an enormous impact on the maintenance of cell integrity. A variety of immunological processes depend on the activity of nicotinamide phosphoribosyl transferase (Nampt) and NAD synthesis. Nuvamid research is based on the importance and function of the major NAD metabolizing enzymes, ADP-ribosyltransferases (ARTs), poly-ADP-ribose-polymerases (PARPs), and sirtuins.
Company size
11-50 employees